0001596771-21-000068.txt : 20211104 0001596771-21-000068.hdr.sgml : 20211104 20211104165738 ACCESSION NUMBER: 0001596771-21-000068 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211103 FILED AS OF DATE: 20211104 DATE AS OF CHANGE: 20211104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Price Ben Gil CENTRAL INDEX KEY: 0001417915 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37809 FILM NUMBER: 211380907 MAIL ADDRESS: STREET 1: 8297 CHAMPIONS GATE BLVD. #444 CITY: CHAMPIONS GATE STATE: FL ZIP: 33896 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NeuroBo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001638287 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472389984 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 BERKELEY ST. STREET 2: FL 19 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: (857) 702-9600 MAIL ADDRESS: STREET 1: 200 BERKELEY ST. STREET 2: FL 19 CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: Gemphire Therapeutics Inc. DATE OF NAME CHANGE: 20150331 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2021-11-03 0 0001638287 NeuroBo Pharmaceuticals, Inc. NRBO 0001417915 Price Ben Gil C/O NEUROBO PHARMACEUTICALS, INC. 200 BERKELEY STREET, OFFICE 19TH FLOOR BOSTON MA 02116 0 1 0 0 CEO and President Nonstatutory Stock Option (right to buy) 2.04 2021-11-03 4 A 0 616666 0 A 2031-11-03 Common Stock 616666 616666 D 266,666 shares subject to the option vest on the first anniversary of the vesting commencement date, November 3, 2021, and the remaining 350,000 shares subject to the option vest on the second anniversary of the vesting commencement date, subject to the Reporting Person's continuous service. /s/ Ben Gil Price 2021-11-04